1 min read
Add as a preferred source on Google

LeonaBio Posts $0.89 Q3 GAAP Loss Per Share, Missing Estimates by 20 Cents

Cash, cash equivalents and investments totaled $32.3 million at Sept. 30, down from $88.3 million at year-end 2025.

A shallow pool of liquid rests at the bottom of a clear vessel / TokenPost.ai
A shallow pool of liquid rests at the bottom of a clear vessel / TokenPost.ai

LeonaBio, Inc. (LONA) posted a third-quarter GAAP loss of $0.89 per share, 20 cents worse than estimates, as cash and investments fell and quarterly operating cash use increased.

Cash, cash equivalents and investments totaled $32.3 million as of Sept. 30, 2026, down from $88.3 million at the end of 2025.

Net cash used in operations was $18.98 million in the quarter ended Sept. 30, compared with $4.7 million in the same quarter of 2025.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…